StockNews.com started coverage on shares of Bellerophon Therapeutics (NASDAQ:BLPH – Free Report) in a research note published on Thursday. The firm issued a hold rating on the biotechnology company’s stock.
Bellerophon Therapeutics Stock Performance
Shares of NASDAQ:BLPH opened at $0.04 on Thursday. Bellerophon Therapeutics has a 52-week low of $0.03 and a 52-week high of $0.46. The company has a market capitalization of $428,155.00, a P/E ratio of -0.04 and a beta of 0.73. The company has a 50-day simple moving average of $0.04 and a 200 day simple moving average of $0.05.
Bellerophon Therapeutics Company Profile
Further Reading
- Five stocks we like better than Bellerophon Therapeutics
- What Does a Stock Split Mean?
- Is Merck Stock Undervalued After Its Colossal Earnings Growth?
- Stock Ratings and Recommendations: Understanding Analyst Ratings
- Top 5 ETFs for Every Investor: From Semiconductors to Defense
- What is a Special Dividend?
- Blade Air Mobility: This Under-the-Radar Stock Could Double Soon
Receive News & Ratings for Bellerophon Therapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Bellerophon Therapeutics and related companies with MarketBeat.com's FREE daily email newsletter.